Back to the directory
Tradewind BioScience
Tradewind translates scientific insight into innovative ways of…
- Founded
- 2017
- Status
- Active
- Stage
- Early
- Team size
- 2
- Location
- San Francisco, CA, USA
- Category
- Biotech & Drug Discovery
- Sector
- Therapeutics
About Tradewind BioScience
Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Federal research funding
1 NIH award totalling $405,552, FY2021.
- Development of a Therapeutic Monoclonal Antibody Against EGFL6, a Mediator of Tumor Growth and Metastasis
Source: NIH RePORTER.
Company data compiled and maintained by Healthcare Discovery.
